Tuesday, December 18, 2012

• Pershing Gold: NOT a Daytrade but a Long-Term Investmentat Forbes (Tue, Dec 18)
• Pershing Gold: Not A Daytrade But A Long Term Investmentat Seeking Alpha (Tue, Dec 18)

Sunday, December 16, 2012

• Biotech Under The Electron Microscope: What's In The Pipeline And Lessons To Be Learnedat Seeking Alpha (Sun, Dec 16)

Sunday, December 9, 2012

• Biotech Weekly Recap: The Market Holds While Biotech Crumblesat Seeking Alpha (Sun, Dec 9)

Tuesday, December 4, 2012

• Investors Chase Neuralstem On Successful Phase I Trialat Seeking Alpha (Tue, Dec 4)
• Maxim Group Highlights 3 Stem Cells Stocks To Consider And 1 To Avoidat Seeking Alpha (Tue, Dec 4)
• Biotech Industry Skyrockets in 2012 as FDA New Drug Approval Rate IncreasesMarketwired (Tue, Dec 4)

Wednesday, November 28, 2012

• Is NeuralStem The Next Sarepta?at Seeking Alpha (Wed, Nov 28)

Tuesday, November 27, 2012

• 4 Biotech Stocks Under $10 Moving Higherat TheStreet (Tue, Nov 27)

Wednesday, November 14, 2012

• The Stem Cell Sector Further Validates Itself With A Successful Q3at Seeking Alpha (Wed, Nov 14)

Monday, November 12, 2012

• An Exciting Week In Cell Therapyat Seeking Alpha (Mon, Nov 12)

Friday, November 9, 2012

• NEURALSTEM, INC. Files SEC form 8-K, Results of Operations and Financial Condition, Financial Statements and ExhibitsEDGAR Online (Fri, Nov 9)
• NEURALSTEM, INC. Files SEC form 10-Q, Quarterly ReportEDGAR Online (Fri, Nov 9)

Thursday, November 8, 2012

• Stem Cell Research Continues to Make Major Breakthroughs in 2012Marketwired (Thu, Nov 8)

Wednesday, November 7, 2012

• NeoStem To Create Value With Billion Dollar Potentialat Seeking Alpha (Wed, Nov 7)

Tuesday, November 6, 2012

• Neuralstem Is Speculative, But Its Work In Stem Cell Therapy Can't Be Ignoredat Seeking Alpha (Tue, Nov 6)

Tuesday, October 23, 2012

• Fish Oil Approach To Neurological Treatment: Neuralstem Vs. Forest Labs And Acordaat Seeking Alpha (Tue, Oct 23)

Friday, October 19, 2012

• NEURALSTEM, INC. Files SEC form 8-K, Other Events, Financial Statements and ExhibitsEDGAR Online (Fri, Oct 19)

Thursday, October 18, 2012

• Healthcare Business Roundup: StemCells Kicks Off With A Buy, Neuralstem Begins Testat Wall St. Cheat Sheet (Thu, Oct 18)

Wednesday, October 17, 2012

• FDA Considering Faster Pathway for Treatments of Deadly or Debilitating DiseasesMarketwired (Wed, Oct 17)

Tuesday, October 16, 2012

• Healthcare Business Roundup: Gilead Falls On Rivals’ Success, Neuralstem’s Positive Resultsat Wall St. Cheat Sheet (Tue, Oct 16)
• Nobel Prize Validates Recent Stem Cell Headlinesat Seeking Alpha (Tue, Oct 16)

Monday, October 15, 2012

• Neuralstem reports positive results of NSI-566 spiral cord cellsat theflyonthewall.com (Mon, Oct 15)

Wednesday, October 10, 2012

• 3 Stocks to Get on Your Watchlistat Motley Fool (Wed, Oct 10)
• 4 Biotechs That Just Got Mauled By Bearsat Seeking Alpha (Wed, Oct 10)

Add CUR News to My Yahoo!